|
|
|
Cathleen Cooper, Ph.D.
IRG Chief
Oncology 1 – Basic Translational (OBT)
Division of Basic and Integrative Biological Sciences
Scientific Review Officer
Cancer Etiology (CE)
Oncology 1 – Basic Translational (OBT)
Scientific Review Officer
Cancer Genetics (CG)
Oncology 1 – Basic Translational (OBT)
|
| |
NIH/CSR
Center for Scientific Review, Room 6196
6701 Rockledge Dr. Bethesda, MD 20892 |
| |
|
Email: cooperc@csr.nih.gov |
Phone Number: 301-443-4512
|
|
Dr. Cathleen Cooper is Chief of the Oncology 1: Basic and Translational IRG. She came to this position after eight years as the Scientific Review Officer of CSR’s Experimental Immunology (EI) and Transplantation, Tolerance and Tumor Immunology (TTT) study sections. Dr. Cooper is active in outreach activities to promote the NIH/CSR mission to the extramural community, including lectures on the peer review process and mock study section presentations. Dr. Cooper earned a Ph.D. in pathology at the University of Southern California where she studied naturally occurring delayed-type hypersensitivity reactions to mycobacteria. She did her postdoctoral training in molecular immunology at Columbia University then went to the University of Massachusetts Medical School as an assistant professor in the Department of Cell Biology and the Cancer Center. There, she led a research team studying the molecular regulation of early events in hematopoietic development with special emphasis on B lymphocyte and neutrophil differentiation. Her work was funded by NIH, American Cancer Society, and private foundations. |
Last Update 11/25/2009
[Organizational
Chart]
Any content changes, comments or suggestions should be provided to the
CSR IT Directory@mail.nih.gov
|